BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 33401116)

  • 1.
    Zhao L; Qiu X; Wang R; Wang D
    J Pharm Biomed Anal; 2021 Feb; 195():113869. PubMed ID: 33401116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UPLC-QTOF/MS-based metabolomics analysis of plasma reveals an effect of Xue-Fu-Zhu-Yu capsules on blood-stasis syndrome in CHD rats.
    Zhao Y; Nie S; Yi M; Wu N; Wang W; Zhang Z; Yao Y; Wang D
    J Ethnopharmacol; 2019 Sep; 241():111908. PubMed ID: 31029757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolomics study on the therapeutic effect of traditional Chinese medicine Xue-Fu-Zhu-Yu decoction in coronary heart disease based on LC-Q-TOF/MS and GC-MS analysis.
    Yi M; Li Q; Zhao Y; Nie S; Wu N; Wang D
    Drug Metab Pharmacokinet; 2019 Oct; 34(5):340-349. PubMed ID: 31474470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ¹H NMR-based metabolomics approach to evaluate the effect of Xue-Fu-Zhu-Yu decoction on hyperlipidemia rats induced by high-fat diet.
    Song X; Wang J; Wang P; Tian N; Yang M; Kong L
    J Pharm Biomed Anal; 2013 May; 78-79():202-10. PubMed ID: 23501440
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Yi M; Dai X; Li Q; Zhao Y; Nie S; Wang D
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Jun; 46(6):591-600. PubMed ID: 34275927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of Xuefu Zhuyu Decoction in the treatment of coronary heart disease based on integrated metabolomics and network pharmacology approach.
    Yang Y; Su C; Zhang XZ; Li J; Huang SC; Kuang HF; Zhang QY
    J Chromatogr B Analyt Technol Biomed Life Sci; 2023 May; 1223():123712. PubMed ID: 37060624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma metabolomics-based reveals the treatment mechanism of ShenGui capsule for application to coronary heart disease in a rat model.
    Wang D; Guo J; Liu T; Zhou X; Yang Z; Shi C; Wang W; Li R; Zhang Y; Junzhang ; Yan J; Zhu X; Li Y; Gong M; Cui Y; Wu X
    Anal Biochem; 2022 Apr; 642():114480. PubMed ID: 34813769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The efficacy of Xue Fu Zhu Yu prescription for hyperlipidemia: A meta-analysis of randomized controlled trials.
    Wang S; Qiu XJ
    Complement Ther Med; 2019 Apr; 43():218-226. PubMed ID: 30935534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolomics Profiling of the Effects of Taurine Supplementation on Dyslipidemia in a High-Fat-Diet-Induced Rat Model by
    Kim KS; Bang E
    Adv Exp Med Biol; 2017; 975 Pt 1():329-336. PubMed ID: 28849467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Untargeted serum metabolomics reveals Fu-Zhu-Jiang-Tang tablet and its optimal combination improve an impaired glucose and lipid metabolism in type II diabetic rats.
    Tao Y; Chen X; Cai H; Li W; Cai B; Chai C; Di L; Shi L; Hu L
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Jan; 1040():222-232. PubMed ID: 27866845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An integrative urinary metabolomic study of the therapeutic effect of Guizhi Fuling capsule on primary dysmenorrheal rats based
    Xiong Z; Lang L; Gao X; Xiao W; Wang Z; Zhao L
    J Pharm Biomed Anal; 2019 Feb; 164():750-758. PubMed ID: 30476863
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An NMR metabolomics investigation of perturbations after treatment with Chinese herbal medicine formula in an experimental model of sepsis.
    Li Y; Liu H; Wu X; Li D; Huang J
    OMICS; 2013 May; 17(5):252-8. PubMed ID: 23594183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolomics analysis of Danggui Sini decoction on treatment of collagen-induced arthritis in rats.
    Cheng B; Zheng H; Wu F; Wu J; Liu X; Tang C; Lu S; Chen Z; Song F; Ruan J; Zhang H; Song H; Liu W; Guo H; Liang Y; Su Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2017 Sep; 1061-1062():282-291. PubMed ID: 28763759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolic Profiling Analysis of Patients With Coronary Heart Disease Undergoing Xuefu Zhuyu Decoction Treatment.
    Tao T; He T; Wang X; Liu X
    Front Pharmacol; 2019; 10():985. PubMed ID: 31551786
    [TBL] [Abstract][Full Text] [Related]  

  • 15.
    Luo D; Zhang X; Xu X
    Anal Biochem; 2023 Jun; 670():115138. PubMed ID: 37024002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma-metabolite-biomarkers for the therapeutic response in depressed patients by the traditional Chinese medicine formula Xiaoyaosan: A (1)H NMR-based metabolomics approach.
    Liu CC; Wu YF; Feng GM; Gao XX; Zhou YZ; Hou WJ; Qin XM; Du GH; Tian JS
    J Affect Disord; 2015 Oct; 185():156-63. PubMed ID: 26186531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metabolomics coupled with integrative pharmacology reveal the protective effect of FangjiHuangqi Decoction against adriamycin-induced rat nephropathy model.
    Zhang WN; Yang L; He SS; Qin XM; Li AP
    J Pharm Biomed Anal; 2019 Sep; 174():525-533. PubMed ID: 31252309
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomics reveals the effect of Xuefu Zhuyu Decoction on plasma metabolism in rats with acute traumatic brain injury.
    Feng D; Xia Z; Zhou J; Lu H; Zhang C; Fan R; Xiong X; Cui H; Gan P; Huang W; Peng W; He F; Wang Z; Wang Y; Tang T
    Oncotarget; 2017 Nov; 8(55):94692-94710. PubMed ID: 29212259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shenling Baizhu San improves functional dyspepsia in rats as revealed by
    Zhang S; Xu Z; Cao X; Xie Y; Lin L; Zhang X; Zou B; Liu D; Cai Y; Liao Q; Xie Z
    Anal Methods; 2020 May; 12(18):2363-2375. PubMed ID: 32930262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrating candidate metabolites and biochemical factors to elucidate the action mechanism of Xue-sai-tong injection based on (1)H NMR metabolomics.
    Jiang M; Zhao X; Wang L; Xu L; Zhang Y; Li Z
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Jul; 1026():87-96. PubMed ID: 26862062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.